Assertio Holdings, Inc.
ASRTNASDAQHealthcare● Active
$23.43
$-0.01(-0.04%)
Market Cap$151408877
P/E Ratio—
52W High$23.47
52W Low$8.61
Assertio Holdings, Inc. (ASRT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ASRT · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
-$2.93
Est. -$1.91 · -53.4%
Revenue
$0.01B
Est. $0.01B · +10.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
ASRT reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.02
Rev. $0.33B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.02
Rev. Est.$0.33B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | -$0.36 | — | — | — | $0.03B | — |
| ▼ Q2 FY2026 | May 8, 2026 | -$1.91 | -$2.93 | -53.4% | $0.01B | $0.01B | +10.8% |
| ▲ Q1 FY2026 | Mar 16, 2026 | -$3.05 | -$1.86 | +39.0% | $0.01B | $0.01B | +118.5% |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$1.20 | $1.65 | +237.5% | $0.05B | $0.01B | +697.9% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -$0.10 | -$0.17 | -70.0% | $0.03B | $0.03B | -0.3% |
| ▼ Q2 FY2025 | May 12, 2025 | -$0.06 | -$0.14 | -133.3% | $0.03B | $0.03B | -3.8% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -$0.05 | -$0.11 | -120.0% | $0.03B | $0.03B | +5.5% |
| ▲ Q4 FY2024 | Nov 11, 2024 | -$0.05 | -$0.03 | +40.0% | $0.03B | $0.03B | +1.9% |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
-$0.36
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026Miss
EPS Actual
-$2.93
EPS Est.
-$1.91
EPS Surpr.
-53.4%
Revenue
$0.01B
Q1 FY2026
Mar 16, 2026Beat
EPS Actual
-$1.86
EPS Est.
-$3.05
EPS Surpr.
+39.0%
Revenue
$0.01B
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
$1.65
EPS Est.
-$1.20
EPS Surpr.
+237.5%
Revenue
$0.05B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
-$0.17
EPS Est.
-$0.10
EPS Surpr.
-70.0%
Revenue
$0.03B
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$0.14
EPS Est.
-$0.06
EPS Surpr.
-133.3%
Revenue
$0.03B
Q1 FY2025
Mar 12, 2025Miss
EPS Actual
-$0.11
EPS Est.
-$0.05
EPS Surpr.
-120.0%
Revenue
$0.03B
Q4 FY2024
Nov 11, 2024Beat
EPS Actual
-$0.03
EPS Est.
-$0.05
EPS Surpr.
+40.0%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.38 | $0.51 | $0.59 | 1 |
| Q3 FY2027 | $0.21 | $0.28 | $0.32 | 1 |
| Q2 FY2027 | $0.10 | $0.13 | $0.15 | 1 |
| Q1 FY2027 | $0.14 | $0.19 | $0.22 | 1 |
| Q4 FY2026 | $0.37 | $0.50 | $0.58 | 1 |
| Q3 FY2026 | $0.27 | $0.36 | $0.42 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 8, 2026 | -53.4% | $22.37 | $22.50 | +0.58% |
| ▲ Q1 FY2026 | Mar 16, 2026 | +39.0% | $11.54 | $11.77 | +1.99% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +237.5% | $11.41 | $12.02 | +5.35% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -70.0% | $10.94 | $10.88 | -0.55% |
| ▼ Q2 FY2025 | May 12, 2025 | -133.3% | $9.15 | $9.23 | +0.87% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -120.0% | $11.60 | $11.68 | +0.69% |
| ▲ Q4 FY2024 | Nov 11, 2024 | +40.0% | $12.75 | $13.88 | +8.86% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -25.0% | $18.75 | $18.45 | -1.60% |
Q2 FY2026+0.58%
Report Date
May 8, 2026
EPS Beat/Miss
-53.4%
Price Before
$22.37
Price After
$22.50
Q1 FY2026+1.99%
Report Date
Mar 16, 2026
EPS Beat/Miss
+39.0%
Price Before
$11.54
Price After
$11.77
Q4 FY2025+5.35%
Report Date
Nov 10, 2025
EPS Beat/Miss
+237.5%
Price Before
$11.41
Price After
$12.02
Q3 FY2025-0.55%
Report Date
Aug 11, 2025
EPS Beat/Miss
-70.0%
Price Before
$10.94
Price After
$10.88
Q2 FY2025+0.87%
Report Date
May 12, 2025
EPS Beat/Miss
-133.3%
Price Before
$9.15
Price After
$9.23
Q1 FY2025+0.69%
Report Date
Mar 12, 2025
EPS Beat/Miss
-120.0%
Price Before
$11.60
Price After
$11.68
Q4 FY2024+8.86%
Report Date
Nov 11, 2024
EPS Beat/Miss
+40.0%
Price Before
$12.75
Price After
$13.88
Q3 FY2024-1.60%
Report Date
Aug 7, 2024
EPS Beat/Miss
-25.0%
Price Before
$18.75
Price After
$18.45
Avg Beat Reaction+5.40%
Avg Miss Reaction-0.00%
Beat Rate3 / 8 quarters
Largest Move+8.86% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ASRT ends December
Assertio Holdings, Inc. (ASRT) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $-2.93 — missing the analyst consensus of $-1.91 by -53.4%. The next ASRT earnings date is expected around September 1, 2026.
Each quarter, investors track ASRT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ASRT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ASRT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ASRT earnings · 5 questionsAssertio Holdings, Inc.'s next earnings report is expected around September 1, 2026. ASRT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ASRT historically reports after market close (AMC).
ASRT earnings datewhen is ASRT earningsASRT next earnings datewhen does ASRT report earningsASRT earnings calendar
▸ Source: FMP · Assertio Holdings, Inc. SEC filings · US GAAP · Assertio Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026